[Cost effectiveness analysis of two adjuvant regimens in the treatment of colorectal cancer: an interpretation of the MOSAIC Study].
Rebesco
Barbara
B
Unità Operativa Farmacia, Azienda Ospedaliera Universitaria San Martino, Genova.
Cantagalli
Elena
E
Amalfitano
Maria Elvira
ME
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant / Q000191:economics; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000191:economics* / Q000601:surgery; D003362:Cost-Benefit Analysis; D005472:Fluorouracil / Q000008:administration & dosage / Q000191:economics; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage / Q000191:economics; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000191:economics; D016032:Randomized Controlled Trials as Topic
D009944:Organoplatinum Compounds; D002955:Leucovorin; D005472:Fluorouracil